Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice Mariottini

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Frontiers in Neurology|June 13, 2022
Investigating Serum sHLA-G Cooperation With MRI Activity and Disease-Modifying Treatment Outcome in Relapsing-Remitting Multiple SclerosisRoberta Amoriello, Roberta Rizzo, Alice Mariottini, et al.
Frontiers in Neurology|June 20, 2024
Leptomeningeal enhancement in multiple sclerosis: a focus on patients treated with hematopoietic stem cell transplantationLeonardo Marchi, Alice Mariottini, Vittorio Viti, et al.
Current Neuropharmacology|January 26, 2024
Disease Modifying Strategies in Multiple Sclerosis: New Rays of Hope to Combat Disability?Carlo Maria Bellanca, Egle Augello, Alice Mariottini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 7, 2025
Aggressive MS and Autologous HSCT: A review on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow TransplantationGiacomo Boffa, Angela Genchi, Alice Mariottini, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 20, 2025
Autologous haematopoietic stem cell transplantation affects long-term progression independent of relapse activity in aggressive multiple sclerosis: a comparative matched studyAlice Mariottini, Anna Chiara Mazzeo, Edoardo Simonetti, et al.
Multiple Sclerosis and Related Disorders|July 12, 2024
Spinal cord size as promising biomarker of disability outcomes after hematopoietic stem cell transplantation in multiple sclerosisAlice Mariottini, Emily H Stack, Govind Nair, et al.
Frontiers in Neurology|March 14, 2022
Intermediate-Intensity Autologous Hematopoietic Stem Cell Transplantation Reduces Serum Neurofilament Light Chains and Brain Atrophy in Aggressive Multiple SclerosisAlice Mariottini, Leonardo Marchi, Chiara Innocenti, et al.
Neurology|July 13, 2021
Autologous Hematopoietic Stem Cell Transplantation in Active Multiple Sclerosis: A Real-world Case SeriesRichard S Nicholas, Elijah E Rhone, Alice Mariottini, et al.
Annals of Neurology|April 19, 2025
Effectiveness of Autologous Hematopoietic Stem Cell Transplantation versus Alemtuzumab and Ocrelizumab in Relapsing Multiple Sclerosis: A Single Center Cohort StudyPaolo Antonio Muraro, Antonio Zito, Alessio Signori, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 5, 2025
Real-world effectiveness of autologous haematopoietic stem cell transplantation for multiple sclerosis in the UKPaolo Antonio Muraro, Majid Kazmi, Eleonora De Matteis, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Frontiers in Neurology|June 13, 2022
Investigating Serum sHLA-G Cooperation With MRI Activity and Disease-Modifying Treatment Outcome in Relapsing-Remitting Multiple SclerosisRoberta Amoriello, Roberta Rizzo, Alice Mariottini, et al.
Frontiers in Neurology|June 20, 2024
Leptomeningeal enhancement in multiple sclerosis: a focus on patients treated with hematopoietic stem cell transplantationLeonardo Marchi, Alice Mariottini, Vittorio Viti, et al.
Current Neuropharmacology|January 26, 2024
Disease Modifying Strategies in Multiple Sclerosis: New Rays of Hope to Combat Disability?Carlo Maria Bellanca, Egle Augello, Alice Mariottini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 7, 2025
Aggressive MS and Autologous HSCT: A review on behalf of the Autoimmune Diseases Working Party of the European Society for Blood and Marrow TransplantationGiacomo Boffa, Angela Genchi, Alice Mariottini, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 20, 2025
Autologous haematopoietic stem cell transplantation affects long-term progression independent of relapse activity in aggressive multiple sclerosis: a comparative matched studyAlice Mariottini, Anna Chiara Mazzeo, Edoardo Simonetti, et al.
Multiple Sclerosis and Related Disorders|July 12, 2024
Spinal cord size as promising biomarker of disability outcomes after hematopoietic stem cell transplantation in multiple sclerosisAlice Mariottini, Emily H Stack, Govind Nair, et al.
Frontiers in Neurology|March 14, 2022
Intermediate-Intensity Autologous Hematopoietic Stem Cell Transplantation Reduces Serum Neurofilament Light Chains and Brain Atrophy in Aggressive Multiple SclerosisAlice Mariottini, Leonardo Marchi, Chiara Innocenti, et al.
Neurology|July 13, 2021
Autologous Hematopoietic Stem Cell Transplantation in Active Multiple Sclerosis: A Real-world Case SeriesRichard S Nicholas, Elijah E Rhone, Alice Mariottini, et al.
Annals of Neurology|April 19, 2025
Effectiveness of Autologous Hematopoietic Stem Cell Transplantation versus Alemtuzumab and Ocrelizumab in Relapsing Multiple Sclerosis: A Single Center Cohort StudyPaolo Antonio Muraro, Antonio Zito, Alessio Signori, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 5, 2025
Real-world effectiveness of autologous haematopoietic stem cell transplantation for multiple sclerosis in the UKPaolo Antonio Muraro, Majid Kazmi, Eleonora De Matteis, et al.
Pageof 5